Other clinical trials currently ongoing related to NM due to breast cancer are evaluating the efficacy of CAR T cell therapy (HER2 CAR) and a bi-specific antibody (HER2Bi) (NCT03696030, NCT03661424). This evidence concerns the gene ERBB2 and breast cancer.